Home / Products / Peptides / Details
video
Chinese Supplier Of High-purity Survodutide (10 Mg/vial) For Research Use

Chinese Supplier Of High-purity Survodutide (10 Mg/vial) For Research Use

Survodutide (development code: BI 456906) is a next-generation, dual-target incretin-based peptide therapeutic jointly developed by the global pharmaceutical company Boehringer Ingelheim and the Danish firm Zealand Pharma. Designed using Zealand Pharma’s proprietary long-acting peptide technology platform, the molecule is administered via a once-weekly subcutaneous injection. It stands as one of the most advanced candidates globally within the class of GLP-1/glucagon (GCG) dual-receptor agonists.

Product Introduction

Clinical Applications

The clinical development of Survodutide primarily focuses on two indications: obesity/overweight and metabolic dysfunction-associated steatohepatitis (MASH). The Phase III SYNCHRONIZE-1 trial demonstrated that, among adults with obesity but without diabetes, those receiving a 6.0 mg dose experienced a 13.0% mean reduction in body weight by week 76, compared to 5.4% in the placebo group. In the context of MASH, Phase II data indicate that the drug significantly improves liver histology and reduces hepatic fat content. Furthermore, exploratory data suggest that the weight loss is driven predominantly by a reduction in adipose tissue, with a relatively minor loss of lean body mass.

 


Mechanism of Action (Pharmacological Mechanism)
The core innovation of Survodutide lies in its synergistic dual-agonism of the GLP-1 and glucagon receptors:
1. GLP-1 Receptor Agonism - "Controlling Intake"
Acts on the hypothalamic feeding centers to significantly enhance satiety and suppress appetite.
Delays gastric emptying, thereby reducing meal size and frequency.
Stimulates glucose-dependent insulin secretion, improving glycemic homeostasis.
2. Glucagon Receptor Agonism - "Increasing Expenditure"
Promotes hepatic glycogenolysis and fatty acid oxidation (β-oxidation), directly boosting energy expenditure.
Facilitates the clearance of hepatic lipids-a key mechanism underlying its efficacy in treating fatty liver.
Together with the GLP-1 pathway, it creates a "reduced intake + increased expenditure" metabolic dual-engine-a pharmacological advantage not found in single-target GLP-1 agents (such as semaglutide).
3. Long-Acting Design
The molecule is modified with a fatty acid chain that allows for reversible binding to albumin, resulting in a half-life that supports once-weekly subcutaneous injection-offering significantly better patient compliance than short-acting peptides.

 

 

 

Benefits in Bodybuilding
The central challenge in bodybuilding and physique sports is how to maximize fat loss while preserving hard-earned muscle mass. Traditional "cutting" phases, which rely on extreme caloric deficits, are often accompanied by a 20–40% loss of lean body mass. The potential value of Survodutide in this context includes:
Selective fat loss: Phase III data indicate that weight loss is "driven primarily by adipose tissue, with a minimal contribution from lean body mass"-the ideal composition of weight loss for those in the bodybuilding community.
Appetite control during contest preparation: The strong satiety effect mediated by the GLP-1 pathway helps counteract the urge to binge-eat-a common challenge during the low-carb phases of contest prep-thereby ensuring strict adherence to dietary protocols.
Targeted visceral fat reduction: A 34% decrease in visceral fat helps refine abdominal definition and enhance muscle separation.
Improved insulin sensitivity: Potentially enhances glycogen utilization efficiency during high-carbohydrate "bulking" phases.
Convenient dosing: Once-weekly injections minimize the disruption that frequent administration might otherwise cause to daily life and training routines.

 

 

 

Dietary and Medication Considerations
Dietary guidelines:
Ensure adequate protein intake (recommended 1.6–2.2 g per kg of body weight) as the primary defense against muscle breakdown.
Opt for smaller, more frequent meals consisting of easily digestible, light foods to significantly alleviate gastrointestinal discomfort.
During the initial phase of treatment, when gastric emptying is delayed, avoid overeating-especially foods high in fat or fiber-to prevent exacerbating nausea or vomiting.
Strictly follow the dose-escalation protocol; do not skip steps or increase the dosage prematurely in an attempt to accelerate results. Clinical studies show that the highest incidence of treatment discontinuation occurs during this escalation phase.
Medication-related notes:
The most common adverse effects are gastrointestinal (nausea, diarrhea, vomiting, and constipation); these are typically mild to moderate and tend to subside over time.
Exercise caution when taking other oral medications: delayed gastric emptying may alter the absorption rate of oral drugs. It is advisable to space out the timing of doses and consult with a healthcare professional.
This class of peptide-based medication is contraindicated for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2).
Individuals with a history of pancreatitis or gallbladder disease should undergo careful evaluation before use.
Do not use in combination with other GLP-1 receptor agonists.

 

 

 

Why Choose Us
In the field of scientific research peptides, the quality of the raw material determines the credibility of your research data. Choosing us means opting for a complete quality chain-from the source to final delivery:
① Direct Manufacturer: No Middlemen, No Markups
We are a primary manufacturer with independent synthesis capabilities-not a trading company or a private-label reseller. By eliminating multiple layers of intermediaries, we avoid unnecessary price markups and delivery delays, ensuring you receive products directly from the source at factory-direct pricing.
② Professional Production Equipment & Robust Processes
Our facilities are equipped with fully automated peptide synthesizers (solid-phase synthesis), preparative HPLC purification systems, and specialized lines for freeze-drying (lyophilization) and sterile packaging. Every stage-from synthesis and purification to freeze-drying-is managed in-house, ensuring consistent quality across all batches.
③ Stable Supply & Reliable Lead Times
With our own production capacity and strategic raw material reserves, we maintain long-term stock of standard specifications and provide transparent lead times for bulk orders. Whether you require small quantities for laboratory use or large-scale institutional procurement, we ensure a stable, uninterrupted supply.
④ High Purity & Consistent Quality
Every batch comes with an HPLC purity report (purity ≥98%) and mass spectrometry (MS) data for molecular weight verification. We guarantee accurate amino acid sequences, eliminating risks such as incorrect sequencing, missing peptides, or excessive endotoxin levels.
⑤ Guaranteed After-Sales Support
Our professional technical support team provides comprehensive guidance on reconstitution, storage, and transportation. Should any quality issues arise, we offer unconditional returns or replacements. We are not looking for one-off transactions, but rather to build long-term partnerships in scientific research.

 


FAQ:
Q: Where are your products manufactured?
A: Our products are manufactured in Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 vials/units.
Q: How soon will my order be shipped?
A: Orders for in-stock items are dispatched within 24 hours.
Q: What purity levels do you offer?
A: Our standard purity is 99%.
Q: Which shipping carriers do you use?
A: We offer shipping via FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days. Q: Can you provide a Certificate of Analysis (COA) and an HPLC (High-Performance Liquid Chromatography) test report?
A: Yes, these can be provided. All products undergo professional testing prior to shipment.
Q: Do you offer OEM (private label) services?
A: Yes, we offer OEM services, subject to a minimum order quantity (MOQ) requirement.
Q: How do you handle after-sales issues?
A: If a quality issue is confirmed to have originated from our production process after the customer has received the goods, we offer free replacement or a refund. We operate with a pragmatic and responsible approach-we respond promptly and handle all issues appropriately, without evasion or shifting responsibility, to fully protect our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.

Hot Tags: chinese supplier of high-purity survodutide (10 mg/vial) for research use, China chinese supplier of high-purity survodutide (10 mg/vial) for research use manufacturers, suppliers, factory

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag